Banque Cantonale Vaudoise’s Collegium Pharmaceutical COLL Stock Holding History

Banque Cantonale Vaudoise’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Buy	+9,457	New	+$323K	0.05%	136

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Banque Cantonale Vaudoise's COLL Position: Q2 2026 in Review

Banque Cantonale Vaudoise opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 9,457 shares worth $342K. The stake represents 0.05% of the portfolio and ranks #136 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Banque Cantonale Vaudoise held 9,457 shares of Collegium Pharmaceutical worth $342K as of Q2 2026.
Collegium Pharmaceutical was a new Banque Cantonale Vaudoise position in Q2 2026.
Collegium Pharmaceutical made up 0.05% of Banque Cantonale Vaudoise's portfolio in Q2 2026, its #136 holding.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2026, filed 31 Jul 2026.